Biofactors 39 (1), 2736
But heres the good news: strength training doesnt just help you keep your muscleit actually boosts your natural GLP-1 production
Our team carries five premium brands, so each recommendation fits you, not one product line
placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes
People are drawn to easy, drug-free options sold online for low prices, especially when theyre priced way below prescription medications that can cost hundreds of dollars monthly
We also don't know whether it's safe for children, so don't take it while nursing, and don't give it to kids